Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M89,859Revenue (TTM) $M19,427Net Margin (%)22.9Altman Z-Score5.8
Enterprise Value $M90,387EPS (TTM) $2.7Operating Margin %23.8Piotroski F-Score6
P/E(ttm)20.2Beneish M-Score-2.2Pre-tax Margin (%)30.5Higher ROA y-yY
Price/Book5.510-y EBITDA Growth Rate %-1.1Quick Ratio1.4Cash flow > EarningsN
Price/Sales4.65-y EBITDA Growth Rate %-4.5Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow55.1y-y EBITDA Growth Rate %145ROA % (ttm)13.6Higher Current Ratio y-yY
Dividend Yield %2.9PEG--ROE % (ttm)29.6Less Shares Outstanding y-yN
Payout Ratio %58.0Shares Outstanding M1,648ROIC % (ttm)20.9Gross Margin Increase y-yN

Gurus Latest Trades with BMY

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

BMY is held by these investors:

BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ANDREOTTI LAMBERTODirector 2017-04-07Sell34,000$53.260.41view
ANDREOTTI LAMBERTODirector 2017-03-28Sell34,000$56.17-4.79view
Schmukler Louis SPres., Global Mfg. & Supply 2017-03-17Sell5,000$56.49-5.33view
Caldarella Joseph CSVP & Controller 2017-03-15Sell8,096$57.29-6.65view
Schmukler Louis SPres., Global Mfg. & Supply 2017-03-14Sell15,000$56.75-5.76view
LEUNG SANDRAEVP, General Counsel 2017-03-06Sell92,405$57.02-6.21view
Samuels Theodore R. IIDirector 2017-02-27Buy12,000$56.77-5.8view
ANDREOTTI LAMBERTODirector 2016-09-08Sell21,600$56.87-5.96view
ANDREOTTI LAMBERTODirector 2016-08-25Sell23,200$59.17-9.62view
ANDREOTTI LAMBERTODirector 2016-07-08Sell23,200$74.45-28.17view

Press Releases about BMY :

Quarterly/Annual Reports about BMY:

News about BMY:

Articles On GuruFocus.com
The Mutual Fund That Is a Top 10 Guru Apr 05 2017 
Weekly Top Insider Buys Highlight for the Week of March 3 Mar 04 2017 
David Tepper Invests Heavily in Pharma in 4th Quarter Feb 16 2017 
Baron Funds' Fifth Avenue Growth Fund Comments on Bristol-Myers Squibb Company Feb 13 2017 
Dodge & Cox Comments on Bristol-Myers Squibb Feb 01 2017 
Dodge & Cox's Stock Fund 4th Quarter Letter to Shareholders Feb 01 2017 
Is Bristol-Meyers a Buy After 39% Price Decline? Jan 29 2017 
Stocks Reach Their 3-Year Low Prices Jan 28 2017 
Manning & Napier’s Top 3 New Holdings Jan 26 2017 
52-Week Company Lows Jan 26 2017 

More From Other Websites
Bristol-Myers Squibb’s BMS-986036 (Pegylated FGF21) Shows Consistent Improvement in Liver Fat,... Apr 22 2017
Bristol-Myers NASH drug reduces liver fat in midstage study Apr 22 2017
Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab) for... Apr 21 2017
Pharma Stock Roundup: J&J Slips on Mixed Q1, Lilly Hit by FDA CRL Apr 21 2017
Is Bristol-Myers Prepping To Outdo Itself In Immuno-Oncology? Apr 20 2017
Bristol-Myers Squibb Co: Buy the Dip? Apr 20 2017
Bristol-Myers 'Holding Up Better,' But Dow's Merck Still Gouging Share Apr 19 2017
The 4 Best Dividend Stocks in Pharmaceuticals Apr 18 2017
Bristol-Myers and Nordic Ink Biomarker Collaboration Deal Apr 18 2017
Exelixis, Inc.: Time to Move On? Apr 18 2017
Blog Coverage Bristol-Myers and Nordic Announce an Agreement for Development of Fibrosis Biomarker... Apr 18 2017
Top Research Reports for Alphabet, Amgen & Lowe's Apr 17 2017
Biogen to License Alzheimer Candidate from Bristol-Myers Apr 17 2017
Bristol-Myers Squibb and Nordic Bioscience Announce Collaboration for Fibrosis Biomarker Technology Apr 17 2017
Bristol-Myers Squibb Co. : BMY-US: Dividend Analysis : April 07th, 2017 (record date) : By the... Apr 14 2017
Could Bristol's Drug Help Biogen Take AbbVie In Alzheimer's? Apr 13 2017
Morgan Stanley Ups Incyte Target to $150 Apr 13 2017
Biogen pays $300M to Bristol-Myers for another potential Alzheimer's drug Apr 13 2017
Bristol-Myers to license two drugs to Biogen, Roche Apr 13 2017
Pharma Stock Roundup: Merck Gets CRL for Label Expansion Effort, Roche Cancer Drug Tops Apr 13 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)